TrialClinIQ | $150,000 | (Apr 29, 2026)
Lighthouse Pharmaceuticals | $12,000,000 | (Apr 29, 2026)
Windmill(US) | $12,000,000 | (Apr 29, 2026)
Certified by Founder
Lodge
Trogenix
start up
United Kingdom
- Edinburgh, Scotland
- 07/10/2025
- Series A
- $94,323,600
Precision genetic medicines, engineered for change
- Industry Biotechnology Research
- Website https://trogenix.com/
- LinkedIn https://www.linkedin.com/company/trogenixbio/
Related People
Ken MacnamaraFounder
United Kingdom -
Greater Edinburgh Area
Ken is the Chief Executive Officer of Trogenix, a biotech uniting cutting-edge technologies in genomics, oncology, immunotherapy, and gene therapy to create a revolutionary therapeutic approach.
IC Realtime | $2,000,000 | (Apr 29, 2026)
Golden Child | $37,000,000 | (Apr 29, 2026)
Hypervision Surgical | $22,962,410 | (Apr 29, 2026)
dehaze | $3,746,192 | (Apr 29, 2026)
Clarasight | $11,500,000 | (Apr 29, 2026)
Liquid Instruments | $50,000,000 | (Apr 29, 2026)
TriFetch | $1,900,000 | (Apr 28, 2026)
Linexa | $2,342,840 | (Apr 28, 2026)
HrFlow.ai | $7,000,000 | (Apr 28, 2026)